Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy

Go back to Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy
(NASDAQ: FSTX) Delayed: 8.85 +0.45 (5.36%)
Previous Close $8.40    52 Week High
Open $8.38    52 Week Low
Day High $9.00    P/E N/A 
Day Low $8.21    EPS
Volume 160,730